BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 17449988)

  • 21. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
    Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes.
    Ong EC
    Oncology; 2008; 74 Suppl 1():72-5. PubMed ID: 18758202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain.
    Rauck R; Ma T; Kerwin R; Ahdieh H
    Pain Med; 2008 Oct; 9(7):777-85. PubMed ID: 18950436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence and long-term effect of oxycodone/paracetamol in chronic noncancer pain: a retrospective study.
    Gatti A; Mammucari M; Sabato E; Masucci L; Sabato AF
    Adv Ther; 2011 May; 28(5):418-26. PubMed ID: 21491171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
    Arora S; Setnik B; Michael D; Hudson JD; Clemmer R; Meisner P; Pixton GC; Goli V; Sommerville KW
    J Opioid Manag; 2014; 10(6):423-36. PubMed ID: 25531960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-controlled analgesia versus oral controlled-release oxycodone - are they interchangeable for acute postoperative pain after laparoscopic colorectal surgeries?
    Ho HS
    Oncology; 2008; 74 Suppl 1():61-5. PubMed ID: 18758200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of oxycodone in polytrauma patients: the "Gemelli" experience.
    Franceschi F; Marini M; Ursella S; Carbone L; Candelli M; Pignataro G; Gabrielli M; Santarelli L; Ojetti V; Giupponi B; Fiore V; Barbaro F; De Marco G; Buccelletti F; Mancini F; Roccarina D; Gigante G; Gasbarrini A; Gasbarrini G; Silveri NG
    Eur Rev Med Pharmacol Sci; 2008; 12(2):123-6. PubMed ID: 18575163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
    Daniels S; Casson E; Stegmann JU; Oh C; Okamoto A; Rauschkolb C; Upmalis D
    Curr Med Res Opin; 2009 Jun; 25(6):1551-61. PubMed ID: 19445652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.
    Beaulieu AD; Peloso P; Bensen W; Clark AJ; Watson CP; Gardner-Nix J; Thomson G; Piraino PS; Eisenhoffer J; Harsanyi Z; Darke AC
    Clin Ther; 2007 Jan; 29(1):49-60. PubMed ID: 17379046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study.
    Likar R; Wittels M; Molnar M; Kager I; Ziervogel G; Sittl R
    Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High dose controlled-release oxycodone in hospice care.
    Bercovitch M; Adunsky A
    J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain.
    Hagen NA; Babul N
    Cancer; 1997 Apr; 79(7):1428-37. PubMed ID: 9083166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Controlled-release oxycodone--a therapeutic option for severe neuropathic pain. Two multicenter observational studies].
    Wörz R; Frank M; Achenbach U
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():71-6. PubMed ID: 15490770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
    Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
    Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
    Ytterberg SR; Mahowald ML; Woods SR
    Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early oral analgesia after fast-track cardiac anesthesia.
    Kogan A; Medalion B; Raanani E; Sharoni E; Stamler A; Pak N; Vidne BA; Eidelman LA
    Can J Anaesth; 2007 Apr; 54(4):254-61. PubMed ID: 17400976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.